References
- SchrieverCAFernándezCRodvoldKADanzigerLHDaptomycin: a novel cyclic lipopeptide antimicrobialAm J Health Syst Pharm2005621145115815914875
- ArbeitRDMakiDTallyFPCampanaroEEisensteinBIThe safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infectionsClin Infect Dis2004381673168115227611
- LiuCBayerACosgroveSEClinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and childrenClin Infect Dis201152e18e5521208910
- JeuLFungHBDaptomycin: a cyclic lipopeptide antimicrobial agentClin Ther2004261728175715639687
- AkimotoYNishimuraHKomiyaMKanekoKFujiiATamuraTAmpicillin concentrations in human dental granuloma after a single oral administration of talampicillinAntimicrob Agents Chemother1988325665673377465
- PolilloMTasciniCLastellaMA rapid high-performance liquid chromatography method to measure linezolid and daptomycin concentrations in human plasmaTher Drug Monit20103220020520216115
- VaudauxPFrancoisPBisognanoCLiDLewDPSchrenzelJComparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureusJ Antimicrob Chemother200352899512775678
- SakoulasGEliopoulosGMAlderJEliopoulosCTEfficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureusAntimicrob Agents Chemother2003471714171812709345
- KimASuecofLASutherlandCAGaoLKutiJLNicolauDPIn vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteersAntimicrob Agents Chemother2008523941394618779352